Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03142789Phase 4Completed
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain, sponsored by Gentofte Hospital. Primary endpoint: Total opioid consumption. Started May 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03142789.